Episode 19: Anti-VEGF Drug Selection and More with Dr. Jeffrey Heier

Dr. Jeffrey Heier

Dr. Jeffrey Heier of Ophthalmic Consultants of Boston joins the show to discuss why he uses bevacizumab as his initial agent for various retinal conditions, the role of laser in his treatment of diabetic retinopathy, and more.